News
Filter
-
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
-
Accelerating progress against dementia
-
Learning from translational research success stories during the COVID-19 pandemic
-
Hackathon brings scientists together to tackle brain health
-
LifeArc and Scottish Government work together to drive Scottish research into rare diseases
-
Covid-19 hub shortlisted for Scottish award
-
Study reveals gene faults underpinning severe COVID-19
-
Living with genetic sight loss – a family story
-
Can an innovative gene therapy help people with Hunter syndrome?
-
Living with a rare but incurable liver disease
-
LifeArc – advancing innovation in rare disease
-
LifeArc elects new Board Chair to drive charity’s ambitious strategy
